Search

Search Constraints

You searched for: Author/Creator Bahary, Nathan

Search Results

13. Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma. Issue 2 (15th December 2019)

14. Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies. (28th December 2016)

16. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Issue 1 (10th April 2019)

17. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. (14th May 2019)

18. Neoadjuvant therapy versus upfront surgery for early‐stage left‐sided pancreatic adenocarcinoma: A propensity‐matched analysis from a national cohort of distal pancreatectomies. Issue 1 (25th October 2020)

19. No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer. Issue 5 (May 2023)

20. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size. Issue 5 (13th April 2021)